![Venkat Thalladi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Venkat Thalladi
Directeur Technique/Scientifique/R&D chez
PROTAGONIST THERAPEUTICS, INC.
Profil
Venkat Thalladi is Chief Technical Officer & Executive Vice President at Protagonist Therapeutics, Inc. starting in 2026.
Formerly, Dr. Thalladi was Senior VP-Chemistry, Manufacturing & Controls at DICE Therapeutics, Inc. Dr. Thalladi earned a doctorate from the University of Hyderabad.
Postes actifs de Venkat Thalladi
| Sociétés | Poste | Début |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2026 |
Anciens postes connus de Venkat Thalladi
| Sociétés | Poste | Fin |
|---|---|---|
| DICE THER | Directeur des opérations | 09/08/2023 |
Formation de Venkat Thalladi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Hyderabad
 University of Hyderabad Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
